Lv41
410 积分 2021-02-17 加入
Toxicologic Pathology Forum*: Summary of the 2024 Society of Toxicologic Pathology Town Hall and 2025 STP Member Survey on Determining and Communicating Adversity
48分钟前
已完结
Adversity Considerations for Thyroid Follicular Cell Hypertrophy and Hyperplasia in Nonclinical Toxicity Studies: Results From the 6th ESTP International Expert Workshop
1小时前
已完结
Characterizing “Adversity” of Pathology Findings in Nonclinical Toxicity Studies
1小时前
已完结
Toxicologic Pathology Forum*: Opinion on Qualitative Severity Descriptors to Express Magnitude of Changes in Clinical Pathology Endpoints in Nonclinical Toxicity Studies
1个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
1个月前
已完结
Anti-NGF monoclonal antibody muMab 911 does not deplete neurons in the superior cervical ganglia of young or old adult rats
2个月前
已完结
Tolerability of hypertonic injectables
2个月前
已完结
The state of the art in secondary pharmacology and its impact on the safety of new medicines
3个月前
已完结
The efficiency of systematic sampling in stereology — reconsidered
3个月前
已完结
药物临床试验期间安全监测计划技术要点
3个月前
已完结
皖公网安备34019202002308
